Elhan Kosar
Geen lopende functies
Profiel
Ms. Elhan Kosar is a Portfolio Manager at Bellevue Asset Management AG.
She joined Bellevue Asset Management in February 2004 from Cantrade Private Bank Zürich, where she had been working for four years as Associate Director in the Investment Research Department and managing the Biotech fund of the bank.
Previously she was a Portfolio Manager at Lombard Odier.
Ms. Kosar holds an MBA from the University of Southern California in Los Angeles and a Bachelor of Arts in Economics from Bogazici University in Istanbul.
She is also a CFA charterholder.
Eerdere bekende functies van Elhan Kosar
| Bedrijven | Functie | Einde |
|---|---|---|
| BB BIOTECH AG | Corporate Officer/Principal | - |
Bellevue Asset Management AG
 Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Analyst-Equity | - |
Opleiding van Elhan Kosar
| University of Southern California | Masters Business Admin |
| Bogazici University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BB BIOTECH AG | Finance |
| Bedrijven in privébezit | 1 |
|---|---|
Bellevue Asset Management AG
Bellevue Asset Management AG Investment ManagersFinance Bellevue Asset Management AG (Bellevue AM) is the wholly-owned asset management subsidiary of Bellevue Group AG (SWX: BBN), an independent Swiss financial group. The firm is headquartered in Küsnacht, Switzerland and has additional offices in Germany, Austria and Luxembourg. Founded in 1993, Bellevue AM provides a diverse spectrum of top-tier investment solutions with a focus on global healthcare sector for private and institutional clients. They offer their flagship investment vehicle, the listed investment company BB Biotech AG. | Finance |
